Who owns Erasca, Inc.?
Prices and market caps: Cboe delayed data, at least 15 minutes delayed. Not real-time. Fundamentals from company filings.
Institutional ownership of ERAS from SEC Form 13F filings across 273 reporting managers. All positions are from one synchronized reporting period — 2026-09-30 books, filed up to 45 days after quarter end — so every row is comparable.
As of the 2026-09-30 reporting period, 273 institutions disclosed 327.2M shares of Erasca, Inc. worth $4.80B — about 95.1% of shares outstanding; the largest disclosed holder is Frazier Life Sciences Management, L.P.. Source: SEC Form 13F filings, parsed by EvidInvest.
273
13F holders
$4.80B
value, 2026 filers
95.1%
of shares outstanding (327.2M sh)
46
new positions (2026 filers)
Top institutional holders
ordered by shares owned · positions as of 2026-09-30 · % of fund = share of the manager's own book · % of co. = share of ERAS's shares outstanding
| # | Manager | Shares | Value | % of fund | % of co. | Δ shares QoQ |
|---|---|---|---|---|---|---|
| 1 | Frazier Life Sciences Management, L.P. | 29.5M | $432.1M | 10.7% | 8.6% | +18.0% |
| 2 | BlackRock, Inc. | 23.7M | $348.0M | 0.0% | 6.9% | +12.2% |
| 3 | RTW INVESTMENTS, LP | 22.4M | $329.1M | 3.3% | 6.5% | +25.1% |
| 4 | Venrock Adviser, LLC | 20.1M | $294.5M | 14.3% | 5.8% | +12.3% |
| 5 | T. Rowe Price Investment Management, Inc. | 17.2M | $252.0M | 0.2% | 5% | -18.9% |
| 6 | VANGUARD CAPITAL MANAGEMENT LLC | 13.9M | $203.9M | 0.0% | 4% | +22.0% |
| 7 | STATE STREET CORP | 13.8M | $202.6M | 0.0% | 4% | +13.4% |
| 8 | Siren, L.L.C. | 13.2M | $193.5M | 4.6% | 3.8% | +15.8% |
| 9 | Capital World Investors | 9.4M | $137.2M | 0.0% | 2.7% | +1228.6% |
| 10 | PRICE T ROWE ASSOCIATES INC /MD/ | 8.7M | $126.8M | 0.0% | 2.5% | +37.9% |
| 11 | VANGUARD PORTFOLIO MANAGEMENT LLC | 8.5M | $123.9M | 0.0% | 2.5% | +253.6% |
| 12 | Paradigm Biocapital Advisors LP | 8.0M | $117.3M | 2.3% | 2.3% | -16.2% |
| 13 | ARCH Venture Management, LLC | 7.1M | $104.0M | 6.4% | 2.1% | 0.0% |
| 14 | GEODE CAPITAL MANAGEMENT, LLC | 6.7M | $98.6M | 0.0% | 2% | +3.4% |
| 15 | Logos Global Management LP | 5.9M | $86.5M | 4.7% | 1.7% | -51.4% |
| 16 | Affinity Asset Advisors, LLC | 5.6M | $82.0M | 3.3% | 1.6% | +6.5% |
| 17 | Soleus Capital Management, L.P. | 5.1M | $74.9M | 2.7% | 1.5% | +89.3% |
| 18 | Cormorant Asset Management, LP | 5.0M | $73.3M | 4.9% | 1.5% | -16.7% |
| 19 | GOLDMAN SACHS GROUP INC | 4.3M | $63.7M | 0.0% | 1.3% | +13.8% |
| 20 | ALLIANCEBERNSTEIN L.P. | 4.2M | $60.9M | 0.0% | 1.2% | +0.8% |
| 21 | Assenagon Asset Management S.A. | 4.1M | $60.5M | 0.1% | 1.2% | +407.9% |
| 22 | Vivo Capital, LLC | 4.0M | $58.9M | 6.5% | 1.2% | -2.6% |
| 23 | BANK OF AMERICA CORP /DE/ | 3.8M | $56.2M | 0.0% | 1.1% | +25.7% |
| 24 | Woodline Partners LP | 3.2M | $47.4M | 0.1% | 0.9% | +14.1% |
| 25 | Janus Henderson Group Ltd.NEW | 3.0M | $44.1M | 0.0% | 0.9% | new |
Source: SEC Form 13F-HR filings (institutional managers over $100M in US-listed positions). 13Fs disclose long positions only, up to 45 days after quarter end; each manager's latest filed quarter is shown per row and dollar values are the manager's filed marks. Aggregates labeled "2026 filers" count only managers whose latest book is a 2026 quarter. Related: valuation · options positioning · supply chain. Research, not investment advice.